BD, Scanwell To Develop At-Home Rapid Test For COVID-19 - Quick Facts

Becton, Dickinson and Company (BDX) and Scanwell Health announced a collaboration to create an at-home rapid test for SARS-CoV-2 using a BD antigen test and the Scanwell Health mobile app. Becton, Dickinson plans to produce a lateral flow antigen test and pair it with the Scanwell mobile app. The app will provide step-by-step instructions on how to collect and transfer a nasal swab sample and use the mobile device's camera to analyze and interpret results.

Scanwell Health, a provider of at-home medical testing, is the first and only to receive FDA 510(k) clearance for an over-the-counter diagnostic smartphone application.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT